Related Experiment Video
Updated: Jan 9, 2026

Orthotopic Implantation of Patient-Derived Cancer Cells in Mice Recapitulates Advanced Colorectal Cancer
Published on: February 10, 2023
Case report of sigmoid colon cancer with synchronous peritoneal metastasis achieving a pathological complete response
Kohei Takehara1, Hiroaki Kasashima1, Tatsunari Fukuoka1
1Department of Gastroenterological Surgery, Osaka Metropolitan University Graduate School of Medicine 1-4-3 Asahimachi, Abeno-ku, Osaka, 545-8585, Japan.
Introduction:
Synchronous peritoneal metastasis occurs in about 5 % of colorectal cancer (CRC) cases, often with other distant metastases. Due to poor drug penetration, chemotherapy is typically ineffective, leading to poor prognosis. Here, we report a rare case of sigmoid colon cancer with synchronous peritoneal metastasis achieving pathological complete response (pCR) after systemic chemotherapy.
Case Presentation:
A 74-year-old man was diagnosed with acute generalized peritonitis from a perforated sigmoid colon cancer with two peritoneal metastases. One peritoneal lesion was left unresected, and sigmoid colectomy with partial jejunal resection was performed. Additionally, postoperative colonoscopy revealed a synchronous cancer in the cecum. Chemotherapy with mFOLFOX6 plus cetuximab was initiated. After 10 cycles, the patient developed strangulation ileus, requiring surgery, during which a peritoneal nodule was resected and showed no viable cancer cells, indicating pCR. Chemotherapy was resumed and completed to 12 cycles. Laparoscopic ileocecal resection for the cecal cancer also achieved pCR. A single peritoneal recurrence was surgically removed. No recurrence has been observed for 7 months.
Discussion:
Reports of pCR with peritoneal metastases are extremely rare. Although the mechanism of the remarkable response in this case remains unclear, given the rarity of pCR in CRC with peritoneal metastasis, further case accumulation and analysis are warranted.
Conclusion:
This is a rare case of pCR to systemic chemotherapy for CRC with synchronous peritoneal metastasis.
More Related Videos
12:45Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
Published on: February 12, 2022
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024